Literature DB >> 15184908

Neurotoxic effects of postnatal thimerosal are mouse strain dependent.

M Hornig1, D Chian, W I Lipkin.   

Abstract

The developing brain is uniquely susceptible to the neurotoxic hazard posed by mercurials. Host differences in maturation, metabolism, nutrition, sex, and autoimmunity influence outcomes. How population-based variability affects the safety of the ethylmercury-containing vaccine preservative, thimerosal, is unknown. Reported increases in the prevalence of autism, a highly heritable neuropsychiatric condition, are intensifying public focus on environmental exposures such as thimerosal. Immune profiles and family history in autism are frequently consistent with autoimmunity. We hypothesized that autoimmune propensity influences outcomes in mice following thimerosal challenges that mimic routine childhood immunizations. Autoimmune disease-sensitive SJL/J mice showed growth delay; reduced locomotion; exaggerated response to novelty; and densely packed, hyperchromic hippocampal neurons with altered glutamate receptors and transporters. Strains resistant to autoimmunity, C57BL/6J and BALB/cJ, were not susceptible. These findings implicate genetic influences and provide a model for investigating thimerosal-related neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184908     DOI: 10.1038/sj.mp.4001529

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  29 in total

Review 1.  The importance of considering all attributes of memory in behavioral endophenotyping of mouse models of genetic disease.

Authors:  Michael R Hunsaker
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

2.  Mercury, vaccines, and autism, revisited.

Authors:  Ellen K Silbergeld
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

3.  Programmed cell death is impaired in the developing brain of FMR1 mutants.

Authors:  Ying Cheng; Joshua G Corbin; Richard J Levy
Journal:  Dev Neurosci       Date:  2013-07-27       Impact factor: 2.984

4.  Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism?

Authors:  J Thomas Curtis; Yue Chen; Daniel J Buck; Randall L Davis
Journal:  Neurosci Lett       Date:  2011-08-31       Impact factor: 3.046

5.  Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain.

Authors:  Mieszko Olczak; Michalina Duszczyk; Pawel Mierzejewski; Teresa Bobrowicz; Maria Dorota Majewska
Journal:  Neurochem Res       Date:  2010-08-28       Impact factor: 3.996

6.  Autism spectrum disorder phenotypes and prenatal exposure to methylmercury.

Authors:  Edwin van Wijngaarden; Philip W Davidson; Tristram H Smith; Katie Evans; Kelley Yost; Tanzy Love; Sally W Thurston; Gene E Watson; Grazyna Zareba; Christine M Burns; Conrad F Shamlaye; Gary J Myers
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

Review 7.  Are neuropathological conditions relevant to ethylmercury exposure?

Authors:  Michael Aschner; Sandra Ceccatelli
Journal:  Neurotox Res       Date:  2009-09-16       Impact factor: 3.911

8.  The Novel Potential Therapeutic Utility of Montelukast in Alleviating Autistic Behavior Induced by Early Postnatal Administration of Thimerosal in Mice.

Authors:  Lobna A Abdelzaher; Ola A Hussein; I E M Ashry
Journal:  Cell Mol Neurobiol       Date:  2020-04-17       Impact factor: 5.046

9.  Mercury-induced cognitive impairment in metallothionein-1/2 null mice.

Authors:  Donnie Eddins; Ann Petro; Ninitia Pollard; Jonathan H Freedman; Edward D Levin
Journal:  Neurotoxicol Teratol       Date:  2007-12-15       Impact factor: 3.763

10.  Effects of Treadmill Exercise on the Expression Level of BAX, BAD, BCL-2, BCL-XL, TFAM, and PGC-1α in the Hippocampus of Thimerosal-Treated Rats.

Authors:  Pouria Navazani; Salar Vaseghi; Mehrdad Hashemi; Mohammad-Reza Shafaati; Mohammad Nasehi
Journal:  Neurotox Res       Date:  2021-05-03       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.